Skip to main content
Skip to main content
CNC logo

Centene Corporation (CNC)

$67.86 $-0.49 (-0.72%) |Strong · 73
Signals are mixed — the Council read leans BUY (64/100) while the AI fundamental score is 73/100 (grade A); the two lenses disagree, so weigh the breakdown below.
MCap: $33.51B| P/E Ratio: 12.1| Vol: 3.86M| Target: $47.86 (-29.5%)| 52-wk range: $25.08 – $62.21
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Centene Corporation (CNC) trades at $67.86 with AI Score 73/100 (Grade A). Centene Corporation is a multi-national healthcare enterprise focused on providing programs and services to under-insured and uninsured individuals in the United States. Market cap: $33.51B, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
Centene Corporation is a multi-national healthcare enterprise focused on providing programs and services to under-insured and uninsured individuals in the United States. The company operates through its Managed Care and Specialty Services segments, offering a range of healthcare solutions.

CNC stock analysis for 2026: Analysts have set a consensus price target of $47.86 for Centene Corporation, suggesting 29.5% downside from the current price of $67.86. The AI MoonshotScore is 73/100, indicating a bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 64/100 · B+

CNC: 1/2 perspectives are bullish.

How is this calculated? →
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · 8 perspectives · See tabs for details →

Centene Corporation (CNC) Healthcare & Pipeline Overview

CEOSarah London
Employees60400
HeadquartersSaint Louis, MO, US
IPO Year2001

Centene Corporation, a key player in the healthcare sector, provides managed care and specialty services, primarily focusing on government-subsidized programs like Medicaid and Medicare. With a national presence, Centene addresses the needs of under-insured and uninsured populations through diverse health plans and specialized offerings.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for CNC?

Centene Corporation presents a mixed investment thesis. The company's focus on government-subsidized healthcare programs provides a stable revenue base, but its negative profit margin of -3.3% raises concerns about profitability. Growth catalysts include expanding Medicaid and Medicare programs and increasing demand for specialty healthcare services. The company's low beta of 0.59 suggests lower volatility compared to the broader market. However, potential risks include regulatory changes, reimbursement pressures, and competition within the managed care industry. Investors should closely monitor Centene's ability to improve its profit margins and navigate the evolving healthcare landscape.

Based on FMP financials and quantitative analysis

CNC Key Highlights

  • Centene operates in the Healthcare sector, specifically within Medical - Healthcare Plans.
  • The company has a market capitalization of $33.51B.
  • Centene employs approximately 60,400 individuals.
  • The company's gross margin is 14.9%.
  • Centene's beta is 0.59, indicating lower volatility compared to the market.

Who Are CNC's Competitors?

CNC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
RPRX Royalty Pharma plc $57.77 +3.57% $24.85B 80
ILMN Illumina, Inc. $188.68 +2.60% $28.55B 91
GMAB Genmab A/S $28.52 +3.17% $17.51B 58
HOLX Hologic, Inc. $76.01 +0.00% $16.97B 58
SNN Smith & Nephew plc $30.25 +5.29% $12.78B 50
ALHC Alignment Healthcare, Inc. $23.80 -0.87% $4.92B 52
GTS Triple-S Management Corporation $35.99 +1.04% 52
HUM Humana Inc. $396.75 -3.09% $47.63B 50

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CNC's Key Strengths?

  • Strong presence in government-sponsored healthcare programs.
  • Diversified service offerings across managed care and specialty services.
  • Extensive network of providers and healthcare facilities.
  • Experienced management team with expertise in healthcare administration.

What Are CNC's Weaknesses?

  • Negative profit margin raises concerns about profitability.
  • Exposure to regulatory changes and reimbursement pressures.
  • High dependence on government funding.
  • Intense competition in the managed care industry.

What Could Drive CNC Stock Higher?

  • Potential for increased enrollment in Medicaid and Medicare programs due to economic conditions.
  • Expansion of telehealth and digital health solutions to improve access to care.
  • Strategic partnerships with healthcare providers to implement value-based care models.

What Are the Key Risks for CNC?

  • Negative return on equity (-28.7%) — the business is not currently generating profit on shareholder capital.
  • Insider selling — insiders were net sellers of roughly $5.2M recently.
  • Regulatory changes that could impact reimbursement rates.
  • Increased competition from other managed care providers.
  • Rising healthcare costs and utilization rates.
  • Cybersecurity threats and data breaches.

What Are the Growth Opportunities for CNC?

  • Expansion of Medicaid and Medicare Programs: The ongoing expansion of Medicaid and Medicare programs presents a significant growth opportunity for Centene. As more states expand Medicaid eligibility and the Medicare population continues to grow, Centene can leverage its expertise in managing government-sponsored healthcare plans to increase its membership and revenue. The market size for Medicaid and Medicare is projected to reach hundreds of billions of dollars in the coming years, offering substantial growth potential for Centene. This expansion is an ongoing catalyst.
  • Increased Demand for Specialty Services: The growing demand for specialty healthcare services, such as pharmacy benefits management, vision and dental care, and behavioral health services, provides another avenue for growth. Centene's Specialty Services segment is well-positioned to capitalize on this trend by offering a comprehensive suite of services to state programs, correctional facilities, healthcare organizations, and employer groups. The market for specialty healthcare services is estimated to be worth billions of dollars annually, offering ample opportunities for Centene to expand its market share. This is an ongoing opportunity.
  • Strategic Acquisitions and Partnerships: Centene can pursue strategic acquisitions and partnerships to expand its geographic reach, enhance its service offerings, and gain access to new markets. Acquiring smaller healthcare providers or partnering with innovative technology companies can strengthen Centene's competitive position and drive long-term growth. The healthcare industry is ripe with acquisition targets and partnership opportunities, allowing Centene to selectively pursue deals that align with its strategic objectives. This is an ongoing opportunity.
  • Technological Innovation and Digital Health Solutions: Investing in technological innovation and digital health solutions can improve efficiency, enhance patient engagement, and reduce costs. Centene can leverage telehealth, mobile health apps, and data analytics to provide more convenient and personalized care to its members. The digital health market is experiencing rapid growth, with increasing adoption of telehealth and remote monitoring technologies. Centene can capitalize on this trend by developing and implementing innovative digital health solutions. This is an ongoing opportunity.
  • Focus on Value-Based Care: Shifting towards value-based care models, which emphasize quality and outcomes over volume, can improve patient satisfaction, reduce costs, and enhance Centene's reputation. By partnering with healthcare providers to implement value-based care programs, Centene can align incentives and drive better health outcomes for its members. The transition to value-based care is a major trend in the healthcare industry, and Centene can position itself as a leader in this area. This is an ongoing opportunity.

What Opportunities Does CNC Have?

  • Expansion of Medicaid and Medicare programs.
  • Growing demand for specialty healthcare services.
  • Strategic acquisitions and partnerships.
  • Technological innovation and digital health solutions.

What Threats Does CNC Face?

  • Changes in government regulations and healthcare policies.
  • Reductions in government funding for healthcare programs.
  • Increased competition from other managed care providers.
  • Rising healthcare costs and utilization rates.

What Are CNC's Competitive Advantages?

  • Scale and market share in government-sponsored healthcare programs.
  • Established relationships with state and federal government agencies.
  • Comprehensive suite of managed care and specialty services.
  • Expertise in managing complex populations with diverse healthcare needs.

What Does CNC Do?

Founded in 1984 and headquartered in St. Louis, Missouri, Centene Corporation has evolved into a multi-national healthcare enterprise dedicated to providing healthcare programs and services to under-insured and uninsured individuals. The company operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment offers health plan coverage through government-subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), long-term services and support, foster care, and Medicare-Medicaid plans. These plans encompass a wide array of services, from primary and specialty physician care to inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision and dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services. Additionally, the segment provides individual, small group, and large group commercial healthcare products. The Specialty Services segment delivers pharmacy benefits management, nurse advice line and after-hours support, vision and dental services, staffing services to correctional systems and government agencies, and services to Military Health System beneficiaries. Centene serves state programs, correctional facilities, healthcare organizations, employer groups, and other commercial entities, utilizing a network of primary and specialty care physicians, hospitals, and ancillary providers.

What Products and Services Does CNC Offer?

  • Provides health plan coverage through government-subsidized programs like Medicaid and Medicare.
  • Offers individual, small group, and large group commercial healthcare products.
  • Delivers pharmacy benefits management services.
  • Provides nurse advice line and after-hours support services.
  • Offers vision and dental services.
  • Provides staffing services to correctional systems and other government agencies.
  • Serves Military Health System eligible beneficiaries.

How Does CNC Make Money?

  • Generates revenue from premiums paid by members enrolled in its health plans.
  • Receives payments from government entities for managing Medicaid and Medicare programs.
  • Earns fees for providing specialty services, such as pharmacy benefits management and vision and dental care.
  • Manages healthcare costs through negotiated rates with providers and utilization management programs.

What Industry Does CNC Operate In?

Centene operates in the dynamic healthcare plans industry, which is characterized by increasing demand for managed care services, driven by the aging population and the expansion of government-sponsored healthcare programs. The industry is highly competitive, with major players vying for market share through product innovation, cost containment, and strategic acquisitions. Regulatory changes and reimbursement pressures pose ongoing challenges. Centene's focus on government-subsidized programs positions it to capitalize on the growing demand for Medicaid and Medicare plans, but it must effectively manage costs and navigate the complex regulatory environment to maintain profitability.

Who Are CNC's Key Customers?

  • Under-insured and uninsured individuals.
  • Individuals enrolled in Medicaid and Medicare programs.
  • Employers offering commercial healthcare products to their employees.
  • State programs and correctional facilities.
  • Military Health System beneficiaries.
AI Confidence: 73% Updated: May 10, 2026

Company Profile

Centene Corporation operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Saint Louis, US. The company is led by CEO Sarah London. CNC has traded publicly since 2001.

ROE -29%Key Financial Metrics

Return on equity for Centene Corporation stands at -28.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.9%, showing how much profit it generates from its asset base. Its free cash flow yield is 20.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.12 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -20.4%, the inverse of the P/E and a quick read on earnings relative to price.

CNC Valuation & Market Position

With a $33.51B market cap, Centene Corporation sits in the large-cap segment of the market. Relative to its peer group, CNC's quantitative score of 73/100 is roughly in line with the peer average of 67/100.

Quarterly Financial Performance: Centene Corporation

Revenue for Centene Corporation came in at $49.94B during Q1 2026. The company recorded net income of $1.54B, with diluted EPS of $3.11. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, CNC averaged $-3.29 in diluted EPS.

F-Score 7/9Financial Health

Centene Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.79 places it in the grey zone, a middle ground that warrants monitoring.

7/8 beatsEarnings Track Record

Centene Corporation has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 48.9% above estimates on average.

FY2026 estForward Outlook

Wall Street analysts project Centene Corporation revenue of about $191.10B for fiscal 2026, with EPS near $3.50. The estimate reflects 12 contributing analysts.

Net sellingInsider Activity

Over the past six months, Centene Corporation insiders filed 10 SEC Form 4 transactions — 3 sales and 7 purchases. On net that is roughly 75K shares disposed (about $5.2M), a signal worth weighing alongside the fundamentals.

CNC Financials

Fundamental Snapshot

Revenue Growth (FY)
+19.4%
Net Income Growth (FY)
-301.9%
EPS Growth (FY)
-315.0%
Return on Equity (TTM)
-28.7%
Current Ratio
1.1

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Strong presence in government-sponsored healthcare programs.
  • Diversified service offerings across managed care and specialty services.
  • Extensive network of providers and healthcare facilities.
  • Experienced management team with expertise in healthcare administration.

Bear Case

  • Negative profit margin raises concerns about profitability.
  • Exposure to regulatory changes and reimbursement pressures.
  • High dependence on government funding.
  • Intense competition in the managed care industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

From the Earnings Call

“The strength of our first quarter performance enables us to increase our full year 2026 adjusted EPS outlook to greater than $3.40, up from our previous expectation of greater than $3.”

— Sarah London, CEO

“We thought it would be prudent to embed in our current guidance a pretax margin for Marketplace around 3% for now, compared to our original forecast of approximately 4%.”

— Andrew Asher, Executive Vice President and Chief Financial Officer

CNC Q1 FY2026 earnings call transcript · 2026-04-28

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $49.94B $1.54B $3.11
Q4 2025 $49.73B -$1.10B -$2.24
Q3 2025 $49.69B -$6.63B -$13.50
Q2 2025 $48.74B -$253M -$0.51

Based on FMP financials and quantitative analysis

CNC Latest News

CNC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNC.

Price Targets

Consensus target: $47.86

CNC MoonshotScore

73/100

What does this score mean?

The MoonshotScore rates CNC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Sarah London

CEO

Sarah London is the CEO of Centene Corporation, a leading multi-national healthcare enterprise. Before becoming CEO, she held various leadership positions within the company, including Vice Chairman. Her experience spans across healthcare strategy, technology, and innovation. She has been instrumental in driving Centene's digital transformation and expanding its focus on value-based care. London's background includes a strong emphasis on leveraging data and analytics to improve healthcare outcomes and efficiency. She is known for her strategic vision and commitment to serving under-insured and uninsured populations.

Track Record: As CEO, Sarah London has focused on enhancing Centene's operational efficiency and expanding its presence in key markets. She has overseen the implementation of new technologies to improve member engagement and streamline healthcare delivery. Under her leadership, Centene has continued to navigate the complex regulatory landscape and adapt to evolving market dynamics. Her strategic decisions have aimed at driving long-term growth and creating value for shareholders.

Common Questions About CNC (Healthcare)

What does Centene Corporation do?

Centene Corporation operates as a multi-national healthcare enterprise, primarily focusing on providing managed care services to individuals through government-subsidized programs, including Medicaid and Medicare. The company offers a range of health plan coverage, including primary and specialty physician care, hospital care, emergency and urgent care, and other essential healthcare services. Additionally, Centene's Specialty Services segment provides pharmacy benefits management, vision and dental services, and other specialized healthcare solutions. The company aims to improve the health and well-being of its members by providing access to affordable and quality healthcare services.

What do analysts say about CNC stock?

Analyst opinions on Centene Corporation (CNC) stock vary, reflecting the complexities of the managed care industry. Key valuation metrics, such as price-to-earnings ratio and enterprise value-to-EBITDA, are closely monitored. Growth considerations include the expansion of Medicaid and Medicare programs, as well as Centene's ability to manage healthcare costs and improve profitability. Analyst consensus typically reflects a neutral to positive outlook, contingent on Centene's ability to execute its strategic initiatives and navigate the evolving regulatory landscape. Investors should conduct their own due diligence and consider their individual risk tolerance before making investment decisions.

What are the main risks for CNC?

Centene Corporation faces several key risks, including regulatory changes, reimbursement pressures, and competition within the managed care industry. Changes in government regulations and healthcare policies could significantly impact Centene's revenue and profitability. Reimbursement rates from government programs are subject to change, which could affect the company's financial performance. Additionally, Centene faces intense competition from other managed care providers, requiring it to continuously innovate and differentiate its service offerings. Rising healthcare costs and utilization rates also pose a challenge, requiring effective cost management strategies.

What are the key factors to evaluate for CNC?

Centene Corporation (CNC) holds an AI score of 73/100 (high). P/E: 12.1x vs the S&P 500's ~20-25x. Analysts target $47.86 (-29%). Not financial advice.

How frequently does CNC data refresh on this page?

CNC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven CNC's recent stock price performance?

Centene Corporation (CNC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong presence in government-sponsored healthcare programs. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CNC overvalued or undervalued right now?

Centene Corporation (CNC) trades at 12.1x earnings. Analysts target $47.86 (-29%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying CNC?

Before investing in Centene Corporation (CNC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are based on the most recent available data.
  • Analyst opinions may vary.
Data Sources

Popular Stocks